give complete detailed explanation on sleep apnea. only include info from standard text like fishman and index journals

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have comprehensive content from all major textbooks. Let me compile the complete detailed explanation.

Sleep Apnea: Complete Detailed Explanation

Sources: Murray & Nadel's Textbook of Respiratory Medicine (6th/7th ed.), Goldman-Cecil Medicine, Guyton & Hall Textbook of Medical Physiology, Braunwald's Heart Disease, Fishman's Pulmonary Diseases and Disorders, and Harrison's Principles of Internal Medicine.

1. Definition and Classification

Sleep-disordered breathing (SDB) is characterized by discrete episodes of absent (apnea) or reduced (hypopnea) breathing, and/or sustained reductions in breathing during sleep (hypoventilation) compared with wakefulness. - Murray & Nadel, p. 2757

Three major types exist:

A. Obstructive Sleep Apnea (OSA)

The most common form of SDB. Results from closure of the upper airway during sleep with continued ventilatory effort. During obstructive apneas, thoracic and abdominal respiratory inductance plethysmography bands demonstrate paradoxical thoracoabdominal motion - chest and abdomen move out of phase because the patient is trying to breathe against a closed airway. - Murray & Nadel, p. 2757

B. Central Sleep Apnea (CSA)

Transient loss of respiratory drive output from the central respiratory controller, with absence of respiratory effort during the event. - Murray & Nadel, p. 2757

C. Mixed Apnea

Events that begin as central apneas but become obstructive - effort is initially absent, then resumes in the latter part of the event. - Murray & Nadel, Table 120.1

2. Definitions of Respiratory Events (AASM Criteria)

Per the American Academy of Sleep Medicine Manual for Scoring Sleep (as cited in Murray & Nadel, Table 120.1):

Event	Definition
Apnea	≥10 sec with ≥90% reduction from baseline in oronasal thermistor airflow
Hypopnea	≥10 sec with ≥30% reduction from baseline in peak nasal pressure airflow, associated with either ≥3% SpO₂ drop or microarousal (Definition 1A) or ≥4% SpO₂ drop (Definition 1B)
RERA	Sequence of breaths ≥10 sec not meeting apnea/hypopnea criteria, with increasing respiratory effort or inspiratory airflow flattening, leading to microarousal
Hypoventilation	Arterial PCO₂ >55 mmHg for ≥10 min, or ≥10 mmHg rise above awake supine values to >50 mmHg for ≥10 min

Murray & Nadel, p. 2758-2759

The standard severity metric is the apnea-hypopnea index (AHI): number of apneas and hypopneas per hour of sleep. The Respiratory Disturbance Index (RDI) adds RERAs to that count. - Murray & Nadel, p. 2758

Severity Classification (ICSD-3 / AASM):

Normal (no OSA): AHI < 5
Mild OSA: AHI 5 to <15
Moderate OSA: AHI 15 to <30
Severe OSA: AHI ≥30

Murray & Nadel, p. 2758

ICSD-3 Diagnostic Criteria for Adult OSA:

OSA is present when (A AND B) OR C are present:

A - At least one of:

Daytime sleepiness, unrefreshing sleep, fatigue, or insomnia
Waking with breath-holding, gasping, or choking
Bed partner reports habitual snoring, breathing interruptions, or both
Diagnosed hypertension, mood disorder, cognitive dysfunction, CAD, CHF, stroke, atrial fibrillation, or type 2 diabetes

B - Sleep recording shows: ≥5 predominantly obstructive events/hour

C - Sleep recording shows: ≥15 predominantly obstructive events/hour (regardless of symptoms)

Murray & Nadel, eTable 120.1, p. 2758-2759

3. Pathogenesis of OSA

Upper Airway Dimensions

The upper airway is a compliant tube lacking rigid bony support in the pharyngeal segment. Its patency depends on a balance between forces that tend to close it (negative intraluminal pressure during inspiration, extraluminal tissue pressure) and forces that maintain patency (upper airway dilator muscle activity). In normal subjects during wakefulness, upper airway muscle activity counterbalances these collapsing forces. During sleep, this muscle activity is reduced, particularly during REM sleep.

The muscles of the pharynx normally keep the passage open to allow air to flow into the lungs during inspiration. During sleep, these muscles relax; some people have an especially narrow passage and relaxation of these muscles causes the pharynx to close completely. - Guyton & Hall, p. 539

Upper Airway Collapsibility - the Pcrit Concept

Upper airway anatomy in OSA patients is characterized by a smaller cross-sectional area of the pharynx, a more inferiorly positioned hyoid bone, a larger tongue volume, and/or more adipose tissue around the airway. The critical closing pressure (Pcrit) - the pressure at which the airway collapses - is higher (less negative) in OSA patients than in normal subjects, meaning the airway closes more easily. - Murray & Nadel, p. 2759-2760

Neuromuscular Factors

Upper airway dilator muscles (particularly the genioglossus) have reduced activation during NREM sleep and markedly diminished activation during REM sleep. In OSA patients, there is an impaired neuromuscular compensatory response to upper airway obstruction. During apneas, progressive asphyxia eventually triggers an arousal, which restores airway patency and resets the cycle.

Fluid Shift Mechanism

In patients with venous insufficiency, heart failure, or end-stage renal disease, fluid that accumulates in the legs during the day redistributes rostrally during recumbency, increasing neck circumference and pharyngeal tissue pressure, thereby increasing upper airway collapsibility. - Murray & Nadel, p. 2760-2761

Ventilatory Instability (Loop Gain)

The concept of "loop gain" - a measure of the propensity for the ventilatory control system to oscillate - is relevant. High loop gain (hypersensitive chemoreflex response) means that a small perturbation in breathing triggers a large compensatory ventilatory overshoot, which itself creates another perturbation, leading to cycling instability. This is a key mechanism in central apneas and also contributes to some obstructive events. - Murray & Nadel, Goldman-Cecil, p. 3907

4. Pathophysiology During Apneic Events

With each obstructive event, the combination of progressive asphyxia, increasingly negative intrathoracic pressure, and autonomic/behavioral arousal leads to acute cardiac and cerebrovascular perturbations including:

Increased afterload of both left and right ventricles
Decreased left ventricular compliance
Increased pulmonary artery pressure
Decreased coronary artery blood flow
Increased myocardial oxygen demand

The abrupt arousal at the termination of obstructive events is associated with peripheral vasoconstriction and an increase in heart rate and systemic blood pressure, even as cardiac output continues to fall. - Goldman-Cecil, p. 3907

Loud snoring and labored breathing occur soon after falling asleep. The snoring becomes louder and is then interrupted by a long silent period during which no breathing (apnea) occurs. Apneic periods result in significant decreases in PO₂ and increases in PCO₂, which greatly stimulate respiration. This stimulation causes sudden attempts to breathe, resulting in loud snorts and gasps followed by snoring and repeated episodes of apnea. These are repeated several hundred times during the night, resulting in fragmented, restless sleep. - Guyton & Hall, p. 539-540

Oxygen saturation sometimes drops to ≤60%, and toward the end of an apneic episode, blood pressure can reach levels as high as 240/130 mmHg. This hemodynamic stress occurs simultaneously with severe hypoxemia, hypercapnia, and adrenergic activation. - Braunwald's Heart Disease, p. 1051

5. Predisposing Factors and Risk Factors

Obesity

The most important modifiable risk factor. Increased fat deposition in the soft tissues of the pharynx and compression from excessive fat masses in the neck narrow the upper airway. The relative risk of OSA increases substantially with increasing BMI. - Guyton & Hall, p. 540; Murray & Nadel, p. 2761

Anatomic Abnormalities

Nasal obstruction
Large tongue (macroglossia)
Enlarged tonsils or adenoids
Retrognathia/micrognathia
Specific shapes of the palate
Narrowing of the bony pharyngeal skeleton

These increase upper airway resistance and promote collapse. - Guyton & Hall, p. 540

Age and Sex

OSA prevalence increases with age. Men are affected more than women, though the sex difference narrows after menopause, suggesting a protective effect of female hormones. In women, sleep apnea is under-recognized despite its significant impact on cardiovascular disease. - Braunwald's Heart Disease, p. 1051; Murray & Nadel, p. 2762

Body Position and Gravity

OSA is often position-dependent, occurring predominantly or exclusively in the supine position ("positional OSA"). In the HypnoLAUS population study, positional OSA was present in 42% of women and 31% of men with AHI ≥5. In the supine position, the tongue falls posteriorly due to gravity, further narrowing the airway. - Murray & Nadel, p. 2762

Genetic Factors

The relative risk for OSA in a first-degree relative of an affected patient is approximately 2.0. Approximately 40% of the genetic variance in AHI is shared with pathways that mediate obesity. The remainder likely resides in genes controlling craniofacial structure, ventilatory control, sleep-wake patterns, and inflammation. - Murray & Nadel, p. 2762

Endocrine Disturbances

Hypothyroidism: OSA reported in 25-35% of untreated patients. Mechanism involves increased mucopolysaccharide deposition in upper airway tissues and altered central respiratory control. Thyroid replacement improves OSA in many patients.
Acromegaly: Sleep-disordered breathing found in ~70% of patients. OSA predominates; CT/MRI reveals larger and thicker soft palates and lateral pharyngeal walls. Biochemical control of acromegaly improves sleep-disordered breathing.
Polycystic Ovarian Syndrome (PCOS): OSA found in up to 70% of women with PCOS. Mechanisms include relative androgen excess and increased central adiposity.

Murray & Nadel, p. 2762; Murray & Nadel block 30, p. 3010-3011

Smoking

Cigarette smoking has been linked to snoring and OSA, with a significant positive dose-response relationship. Mechanisms include worsening of upper airway inflammation and sleep-disruptive effects of nicotine producing respiratory instability. - Murray & Nadel, p. 2762

Alcohol and Drugs

Alcohol worsens snoring and OSA via direct effects on upper airway motor activity and by deepening sleep and impairing arousal responses. Opioids and benzodiazepines depress upper airway tone and respiratory drive, worsening OSA and promoting central apneas. - Murray & Nadel, p. 2762

6. Epidemiology

OSA prevalence depends substantially on the hypopnea scoring criteria and recording technology used. Studies using nasal pressure signals (more sensitive) report higher prevalence than older thermistor-only studies. The prevalence of OSA (AHI ≥5) in the general adult population is approximately 20-30% in men and 10-15% in women by current AASM criteria, making it one of the most common chronic conditions. - Murray & Nadel, p. 2757-2758

Obesity hypoventilation syndrome (OHS) is associated with OSA in 90% of cases and with severe OSA in 70%. - Murray & Nadel, p. 2758

7. Clinical Manifestations

Obstructive Sleep Apnea

The cardinal manifestations of OSA are:

Loud, chronic snoring - habitual, often very disruptive
Excessive daytime somnolence (EDS) - present in approximately 50% of OSA patients
Witnessed sleep-related choking or gasping

Additional symptoms include:

Morning dry mouth (very common)
Morning headache (due to nocturnal hypercapnia)
Insomnia - from repetitive interruption of sleep
Nocturia - possibly mediated via atrial natriuretic receptors; may resolve with treatment
Mood disorders - depression and irritability related to sleep fragmentation and hypoxemia
Perturbations in visual memory and working memory - related to severity of sleep fragmentation and hypoxemia
Night sweats and restless sleep
Confusional parasomnias (sleepwalking, sleep talking) - from arousals during N3 sleep

Goldman-Cecil, p. 3907

Excessive daytime somnolence is quantified by:

Epworth Sleepiness Scale (ESS): Respondent rates likelihood of dozing (0-3 scale) in 8 common situations. A score of ≥11 is commonly accepted as indicating excessive sleepiness. - Murray & Nadel, p. 2782
Multiple Sleep Latency Test (MSLT): Objective laboratory measure of propensity to fall asleep during the day

Resolution of OSA does not necessarily resolve EDS, thereby suggesting the possibility of sustained neurologic perturbation from chronic intermittent hypoxemia and/or arousal. - Goldman-Cecil, p. 3907

Central Sleep Apnea

Cheyne-Stokes breathing - the most common form of CSA - manifests as a crescendo-decrescendo breathing pattern with central apnea or hypopnea as the nadir of the breathing effort cycle. It is prevalent in patients with heart failure, where it is an independent predictor of increased mortality. Patients with heart failure and Cheyne-Stokes breathing tend to have lower awake arterial CO₂ tensions (PaCO₂) than other HF patients. - Goldman-Cecil, p. 3908

CSA is also prevalent in patients using opioids (cluster breathing with central apneas) and in patients with congenital or acquired CNS/cervical spine disorders (noncyclic central apneas or Biot-type breathing). - Goldman-Cecil, p. 3908

8. Pathophysiology of Consequences

Neurocognitive Sequelae

Repeated nocturnal arousals cause sleep fragmentation and deprivation, leading to excessive daytime sleepiness, impaired attention and concentration, impaired memory (particularly working memory and visual memory), and mood disturbances including depression and irritability. The neurocognitive effects are related to both the degree of sleep fragmentation and the severity of intermittent nocturnal hypoxemia. - Goldman-Cecil, p. 3907; Murray & Nadel

Cardiovascular Consequences

Hypertension:

Each obstructive event generates extreme sympathetic activation, causing blood pressure surges that can reach 240/130 mmHg
Sustained increase in sympathetic tone carries over into daytime, producing chronic hypertension
OSA is a recognized cause of secondary hypertension

Cardiac Arrhythmias:

Intermittent hypoxemia, hypercapnia, and vagal activation during apneas promote bradyarrhythmias
Sympathetic surges promote tachyarrhythmias and ectopy
Atrial fibrillation is strongly associated with OSA - listed as a comorbidity in ICSD-3 diagnostic criteria
Complex ventricular arrhythmias and sudden cardiac death risk are increased

Coronary Artery Disease:

Decreased coronary artery blood flow and increased myocardial oxygen demand during apneic events promote ischemia
Untreated sleep apnea in women is associated with 3.5 times greater risk of dying from CVD
This excess risk is reduced to baseline with appropriate CPAP treatment

Heart Failure:

Both OSA and CSA are common in HF
Sleep-disordered breathing is present in a substantial proportion of HF patients
Approximately one-third of HF patients with SDB have central sleep apnea (Cheyne-Stokes), which is associated with increased mortality independent of other known risk factors
In HFrEF patients with OSA, CPAP has been shown to improve quality of life, decrease blood pressure and arrhythmias, and increase LVEF

Harrison's, p. 2491; Braunwald's Heart Disease, p. 1051; Goldman-Cecil

Stroke: OSA is independently associated with increased stroke risk via multiple mechanisms including nocturnal hypertension, atrial fibrillation, and direct hemodynamic perturbations.

Pulmonary Hypertension / Cor Pulmonale:

Repetitive nocturnal hypoxemia causes reactive pulmonary vasoconstriction
Sustained pulmonary hypertension and right heart failure (cor pulmonale) can develop, particularly in severe or untreated OSA
This is recognized under AMA Guides and the Social Security system as a ratable complication

Fishman's, p. 774

Metabolic Consequences

Type 2 diabetes - OSA is a recognized comorbidity; intermittent hypoxemia induces insulin resistance and dysregulation of glucose metabolism
Metabolic syndrome - OSA is associated with central obesity, hypertension, dyslipidemia, and glucose intolerance as a cluster

9. Diagnosis

Clinical Screening Tools

Epworth Sleepiness Scale (ESS):

8 questions about likelihood of dozing in common situations
Scored 0-3 each; total 0-24
Score ≥11 indicates excessive sleepiness

STOP-BANG questionnaire: widely used screening tool in clinical practice (Snoring, Tired, Observed apneas, Pressure, BMI, Age, Neck circumference, Gender).

Berlin Questionnaire: Another validated screening instrument.

Diagnostic Sleep Studies

1. Laboratory Polysomnography (PSG) - the gold standard

Comprehensive multichannel sleep study
Records: EEG (for sleep staging), EOG (eye movements), EMG (chin, leg), EKG, airflow (thermistor + nasal pressure transducer), respiratory effort (thoracic and abdominal inductance plethysmography), SpO₂, snoring
Allows definitive scoring of sleep stages, all respiratory event types, and calculation of AHI, RDI
Can identify position-dependent OSA
Can identify hypopnea arousal-based events that portable monitors cannot

2. Home Sleep Apnea Testing (HSAT) / Out-of-Center Sleep Testing (OCST)

Limited-channel portable monitors
Do not record EEG, so cannot stage sleep or identify RERAs (microarousals not detectable)
Events expressed per hour of recording (not sleep time), so typically underestimate AHI compared with PSG
Appropriate for uncomplicated moderate-to-severe suspected OSA without significant comorbidities
Portable monitors tend to underestimate event indices compared with PSG

Murray & Nadel, p. 2758-2759, eTable 120.1

Objective sleep testing should be obtained before initiation of any therapy for OSA to facilitate decision-making about the most appropriate treatment option. - Murray & Nadel block 28, p. 2818

10. Treatment

Discussions with patients at new diagnosis should include:

Education about pathophysiology relevant to their comorbidities (sympathetic activation and association with hypertension)
Symptoms (nocturia, daytime sleepiness)
Consequences of not treating (risk of major adverse cardiac events)
Treatment options available

Selection of initial therapy should be viewed as nonbinding - when one approach fails, others are often possible. Combination therapy is not uncommon. - Murray & Nadel block 28, p. 2818

Nonsurgical Options

A. Weight Loss Weight loss interventions through dietary approaches and/or exercise are strongly recommended as part of the OSA treatment approach. Even modest weight reduction can substantially reduce AHI.

B. Positional Therapy In patients with position-dependent OSA (primarily supine), devices or positional training to avoid the supine position can be very effective.

C. Continuous Positive Airway Pressure (CPAP)

The most effective and most widely used treatment
Acts as a "pneumatic splint," generating positive pressure in the pharynx that overcomes the collapsing forces and keeps the airway open throughout the respiratory cycle
Immediate effect - efficacy begins on first night of use
In HFrEF patients with OSA, CPAP improves quality of life, decreases blood pressure and arrhythmias, and increases LVEF
Adherence is the primary limiting factor

Adherence to CPAP: PAP therapy is typically very effective in reversing OSA pathophysiology; however, when adherence is suboptimal, symptom-related and health benefits are not realized. Positive predictors of adherence include older age, early PAP adherence, self-reported daytime somnolence. Negative predictors include depression, hypochondriac personality, avoidant coping strategies, and low self-efficacy. Strategies to optimize adherence include disease education, discussion of treatment goals, peer-to-peer support, and early/consistent follow-up. Motivational interviewing and cognitive-behavioral therapy-based interventions have proven beneficial. - Murray & Nadel block 28, p. 2822-2823

D. Auto-CPAP (APAP) Automatically adjusts pressure breath-by-breath based on detected airflow signals, within a set pressure range. More flexible than fixed-pressure CPAP.

E. Bilevel PAP (BPAP) Delivers different pressures for inhalation (IPAP) and exhalation (EPAP). Auto-BPAP is appropriate for treating OSA but not CSA. - Murray & Nadel block 28, p. 2549-2551

F. Oral Appliances (Mandibular Advancement Devices)

Reposition the mandible and tongue anteriorly, enlarging the pharyngeal airway
Require dental evaluation and custom fitting - approximately 3 months to complete evaluation, fabrication, and adjustments
Less effective than CPAP but better tolerated by some patients
Appropriate for mild-moderate OSA or as an alternative when CPAP is not tolerated

G. Hypoglossal Nerve Stimulation

An implanted device that delivers stimulation to the hypoglossal nerve, maintaining genioglossus tone during sleep
Approved for moderate-severe OSA in patients who cannot tolerate CPAP
May also provide benefit in some cases of CSA through phrenic or hypoglossal nerve pacing

H. High-Altitude Considerations Persons with moderate to severe OSA should travel to high altitude with their CPAP machine. For those using autotitrating CPAP, addition of acetazolamide improves AHI by decreasing central apneas and improving nocturnal oxygenation at altitude. - Murray & Nadel block 24, p. 3839

Surgical Options

A. Uvulopalatopharyngoplasty (UPPP) Removes excess soft tissue at the back of the throat. Does not preclude subsequent use of PAP therapy. Less effective and less predictable than CPAP.

B. Tonsillectomy and Adenoidectomy Particularly effective in children with OSA due to adenotonsillar hypertrophy.

C. Maxillomandibular Advancement (MMA) Surgically advances both jaws to permanently enlarge the pharyngeal airway. Most effective surgical option for OSA; can be considered as definitive treatment for patients unlikely to achieve long-term PAP adherence. - Murray & Nadel block 28, p. 2451

D. Tracheostomy Bypasses the obstructed pharyngeal airway entirely. Reserved for severe, life-threatening OSA not amenable to other treatments. - Guyton & Hall, p. 540

Treatment of Central Sleep Apnea (CSA)

Unlike OSA, there is no proven therapy for central sleep apnea. Phrenic or hypoglossal nerve pacing may provide benefit in some cases. In HF with Cheyne-Stokes breathing, treatment of the underlying HF is the primary approach. Auto-BPAP is not appropriate for CSA. - Harrison's, p. 2491

11. Obesity Hypoventilation Syndrome (OHS)

OHS is diagnosed in obese individuals (BMI >30 kg/m²) with SDB and elevated daytime arterial PCO₂ (>45 mmHg) without other identifiable causes. Elevated serum bicarbonate levels can point to the diagnosis, but measurement of CO₂ levels may be needed for confirmation.

OHS is associated with OSA in 90% of cases; with severe OSA in 70%
Risk for OHS increases with higher BMI and lower lung function
Patients typically present with excessive daytime sleepiness and may be hypoxemic with signs of pulmonary hypertension and right heart failure (lower extremity edema)
In up to 40% of cases, they may present with acute hypercapnic respiratory failure

Murray & Nadel, p. 2758

Pathophysiologically, in OHS patients with OSA, chest wall movement is restricted, with resultant mechanical and reflex upper airway narrowing, increased upper airway compliance, ventilatory instability, and impaired ability to compensate for increased upper airway resistance. During REM sleep, erratic neural drive and descending neural inhibition of accessory ventilatory and upper airway muscles may lead to severe alveolar hypoventilation, hypoxemia, and/or obstructive apnea. - Goldman-Cecil, p. 3907

12. Impairment/Disability Assessment

Resting and exercise PFTs are not useful for rating impairment related to sleep apnea. The AMA Guides recommend assessment of the complications of sleep apnea (e.g., cor pulmonale, polycythemia) and rate these according to the appropriate organ systems. Any "add-on" for strictly defining respiratory impairment must be determined by a sleep specialist and should not exceed 3% of total impairment.

Under the Social Security system, sleep apnea is rated according to complications related to affected body systems: chronic pulmonary hypertension, chronic heart failure, or disturbances in mood, cognition, and behavior. - Fishman's, p. 774

Summary Table

Feature	OSA	CSA
Mechanism	Pharyngeal collapse with continued effort	Absent central drive; no effort
PSG finding	Paradoxical thoracoabdominal motion	No respiratory effort
Most common form	Cheyne-Stokes (in heart failure)
Main treatment	CPAP (gold standard)	Treat underlying cause; no proven therapy
Associated with	Obesity, HTN, AF, stroke, DM	Heart failure, opioids, CNS disease
BPAP (auto) appropriate?	Yes	No

Key References from Indexed Journals (as cited in sources above):

Berry RB et al. AASM Manual for Scoring Sleep and Associated Events, Version 2 (cited in Murray & Nadel)
Johns MW. "A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale." Sleep. 1991;14:540-545 (cited in Goldman-Cecil)
American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed. Darien, IL: AASM; 2014 (cited in Murray & Nadel)

This is a shared conversation. Sign in to Orris to start your own chat.